Sfoglia per RIVISTA
MINERVA UROLOGY AND NEPHROLOGY
Collezione ASL Torino 4

  

Items : 23

Increase of continuous treatments and regional citrate anticoagulation during renal replacement therapy in the ICUs of the North-West of Italy from 2007 to 2015. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Jun;75(3):388-397. doi: 10.23736/S2724-6051.22.04699-7. Epub 2022 Mar 11.

2023
ASL Città di Torino
ASL Vercelli
ASL Asti
ASL Torino 4
ASL VCO
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
ASL Alessandria
AOU Alessandria
ASL Novara

Roccatello D; Biancone L; Cusinato S; Besso L; Manganaro M; Mariano F; Vitale C; Chiarinotti D; Boero R; Cesano G; Filiberti O; Costantini L; Borzumati M; Vio P; Chiappero F; Todini V; Marciello A; Savoldi S; Deagostini C; Serra A; Martina G; Salomone M; Formica M; Stramignoni E; Gherzi M; Calabrese G; Roscini E; Maffei S; Marino A; et alii...

Androgen deprivation therapy and cardiovascular risk in prostate cancer. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Oct;74(5):508-517. doi: 10.23736/S2724-6051.22.04847-9. Epub 2022 Apr 26.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Pagliarulo V; Alongi F; Gregori A; Fusco F; Fiori C; DE Nunzio C;

"Augmented reality" applications in urology: a systematic review. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Oct;74(5):528-537. doi: 10.23736/S2724-6051.22.04726-7. Epub 2022 Apr 6.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Porpiglia F; Autorino R; Rivero I; Veneziano D; Gomez Rivas J; Kowalewski KF; Taratkin M; Puliatti S; Checcucci E; Desai A; Roberts S; Gill IS; Cacciamani GE;

Finding novel prognostic factors in metastatic renal cell carcinoma: what does peripheral blood tell us? in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Jun;74(3):372-375. doi: 10.23736/S2724-6051.22.04957-6.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Muselaers S; Roussel E; Pavan N; Pecoraro A; Carbonara U; Kara Ö; Ingels A; Marchioni M; Bertolo R; Erdem S; Campi R; Marandino L; Amparore D;

Comment on: "Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder". in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Jun;74(3):363-364. doi: 10.23736/S2724-6051.22.04949-7.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Cacciamani GE; Kowalewski KF; Rivero Belenchon I; Puliatti S; Gomez Rivas J; Checcucci E; Morozov A; Taratkin M;

Selecting the best candidates for non-surgical management of localized renal masses: the Occam's razor. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Jun;74(3):368-371. doi: 10.23736/S2724-6051.22.04964-3.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Marandino L; Roussel E; Pavan N; Pecoraro A; Carbonara U; Kara Ö; Ingels A; Marchioni M; Erdem S; Bertolo R; Muselaers S; Campi R; Amparore D;

Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Jun;74(3):292-301. doi: 10.23736/S2724-6051.21.04431-1. Epub 2021 Jul 26.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Fiori C; Carrion DM; Egawa S; Papalia R; Kimura T; Briganti A; Ploussard G; Rajwa P; Grossmann NC; Sari Motlagh R; Schuettfort VM; Laukhtina E; Mostafaei H; Katayama S; Quhal F; Mori K; Shariat SF; Esperto F; Pradere B;

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;

Are nephrometry scores accurate for the prediction of outcomes in patients with renal angiomyolipoma treated with robot-assisted partial nephrectomy? A multi-institutional analysis. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):730-737. doi: 10.23736/S2724-6051.22.04848-0. Epub 2022 May 27.

2022
ASL Torino 4
AOU San Luigi di Orbassano

DE Naeyer G; Mottrie A; Rosiello G; Verri P; Amparore D; Fiori C; Porpiglia F; Lazzeri M; Hurle R; Saita A; Casale P; Lughezzani G; Diana P; Uleri A; DE Groote R; Porter J; Buffi N;

Renal surgery in elderly: not all partial nephrectomies should be treated equally. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Aug;74(4):492-496. doi: 10.23736/S2724-6051.22.04956-4.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Roussel E; Muselaers S; Marandino L; Pecoraro A; Pavan N; Carbonara U; Kara Ö; Ingels A; Marchioni M; Erdem S; Amparore D; Bertolo R; Campi R;

Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Aug;74(4):389-399. doi: 10.23736/S2724-6051.21.04530-4. Epub 2021 Jul 26.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Cindolo L; DE Sio M; Damiano R; Fiori C; Verze P; Fusco F; Crocerossa F; Spatafora P; Arcaniolo D; Manfredi C; Otero JR;

Partial vs. radical nephrectomy in non-metastatic pT3a kidney cancer patients: a population-based study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Aug;74(4):445-451. doi: 10.23736/S2724-6051.22.04680-8. Epub 2022 Feb 11.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Porpiglia F; Karakiewicz PI; Fiori C; Peretti D; Tian Z; Checcucci E; Piramide F; Manfredi M; Amparore D; Pecoraro A;

Management of colovesical fistula: a systematic review. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Aug;74(4):400-408. doi: 10.23736/S2724-6051.21.04750-9. Epub 2021 Nov 18.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Sassatelli R; Soriano A; Palicelli A; Biolchini F; Cormio L; Carrieri G; Maestroni UV; Bergamaschi FA; Castro Ruiz C; Campobasso D; Fiori C; Porpiglia F; Sanguedolce F; Zanelli M; Bassi MC; Tumiati D; Zizzo M; Ascani S; Annessi V; Giunta A;

Anterior vs. Retzius-sparing robotic assisted radical prostatectomy: can the approach really make a difference? in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Apr;74(2):137-145. doi: 10.23736/S2724-6051.21.04623-1. Epub 2021 Oct 29.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Roumeguere T; Fiori C; Porpiglia F; Esperto F; Aoun F; Mjaess G; Diamand R; Dasnoy C; Albisinni S; DE Nunzio C;

3D imaging technologies in minimally invasive kidney and prostate cancer surgery: which is the urologists' perception? in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Apr;74(2):178-185. doi: 10.23736/S2724-6051.21.04131-X. Epub 2021 Mar 26.

2022
AOU San Luigi di Orbassano
ASL Torino 4

Autorino R; Fiori C; Manfredi M; Sica M; Granato S; Verri P; Piana A; Volpi G; Piramide F; DE Cillis S; Checcucci E; Pecoraro A; Amparore D; Porpiglia F;

Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Apr;74(2):146-160. doi: 10.23736/S2724-6051.21.04583-3. Epub 2021 Oct 29.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Rivasi G; Gomez Rivas J; Pecoraro A; Papalia R; Pavan N; Mir MC; Minervini A; Marchioni M; Kriegmair M; Klatte T; Kara O; Ingels A; Erdem S; Carbonara U; Capitanio U; Bertolo R; Amparore D; Berni A; Campi R; Roussel E; Ungar A; Serni S; Esperto F;

Are we ready for single overnight stay after robot-assisted partial nephrectomy? in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):858-860. doi: 10.23736/S2724-6051.21.04812-6.

2021
ASL Torino 4
AOU San Luigi di Orbassano

Piramide F; Turri F; Dell'oglio P; Rocco B; Larcher A;

Adverse event assessment in prostate cancer patients receiving androgen deprivation therapy: are we doing enough? in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):870-872. doi: 10.23736/S2724-6051.21.04817-5.

2021
ASL Asti
ASL Torino 4
AOU San Luigi di Orbassano

Tucci M; Turco F; Buttigliero C;

Inferior vena cava involvement in renal cell carcinoma: if you fail to plan, you're planning to fail. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):854-857. doi: 10.23736/S2724-6051.21.04811-4.

2021
ASL Torino 4
AOU San Luigi di Orbassano

Mulders P; Muselaers S; Bertolo R; Erdem S; Ingels A; Marandino L; Roussel E; Marchioni M; Amparore D; Campi R;

Bioethical implications of robotic surgery in urology: a systematic review. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):700-710. doi: 10.23736/S2724-6051.21.04240-3. Epub 2021 Jul 26.

2021
ASL Torino 4
AOU San Luigi di Orbassano

Alloni R; Antonelli A; Prata F; Esperto F; Campanozzi L; Cataldo R; Civitella A; Fiori C; Ghilardi G; Guglielmelli E; Minervini A; Muto G; Rocco B; Sighinolfi C; Pang KH; Simone G; Tambone V; Tuzzolo P; Scarpa RM; Papalia R;

Contemporary management of benign uretero-enteric strictures after cystectomy: a systematic review. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):724-730. doi: 10.23736/S2724-6051.21.04463-3. Epub 2021 Jul 26.

2021
ASL Torino 4
AOU San Luigi di Orbassano

Albisinni S; Aoun F; Mjaess G; Abou Zahr R; Diamand R; Porpiglia F; Esperto F; Autorino R; Fiori C; Tubaro A; Roumeguère T; DE Nunzio C;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;

Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):796-802. doi: 10.23736/S2724-6051.20.04076-X. Epub 2021 Jan 13.

2021
ASL Torino 4

Vartolomei MD; Lucarelli G; Marchioni M; Ferro M; Soria F; Terracciano D; Mistretta FA; Luzzago S; Buonerba C; Cantiello F; Mari A; Minervini A; Veccia A; Antonelli A; Musi G; Hurle R; Busetto GM; Del Giudice F; Chung BI; Berardinelli F; Perdonà S; Del Prete P; Mirone V; Borghesi M; Porreca A; Bove P; Autorino R; Crisan N; Abu Farhan AR; et alii...